Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30701350 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL30701363 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL30701401 | 1.00 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL16927604 | 0.93 | PPARG (0.51) | MAPTPPARDPPARGGPR132 | |
| SCHEMBL31026920 | 0.93 | PPARG (0.51) | MAPTPPARDPPARGGPR132 | |
| SCHEMBL14039917 | 0.93 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL16927601 | 0.93 | PPARG (0.51) | MAPTPPARDPPARGGPR132 | |
| SCHEMBL16927610 | 0.93 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL16927600 | 0.93 | PPARG (0.51) | MAPTPPARDPPARGGPR132 | |
| SCHEMBL29155796 | 0.93 | GPR84 (0.48) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117222414-A | Compounds for activating constant natural killer T-cells and methods for eliminating inflammatory senescent cells | 脱落性治疗公司 | 2023-12-12 | — | — | CN | disclosed |